IRIS Accounts Production v24.1.0.578 08018899 Board of Directors 1.1.23 31.12.23 31.12.23 26.3.24 false true false false true true false Auditors Opinion Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh080188992022-12-31080188992023-12-31080188992023-01-012023-12-31080188992021-12-31080188992022-01-012022-12-31080188992022-12-3108018899ns15:EnglandWales2023-01-012023-12-3108018899ns14:PoundSterling2023-01-012023-12-3108018899ns10:Director12023-01-012023-12-3108018899ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3108018899ns10:SmallEntities2023-01-012023-12-3108018899ns10:Audited2023-01-012023-12-3108018899ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3108018899ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3108018899ns10:AbridgedAccounts2023-01-012023-12-3108018899ns10:OrdinaryShareClass12023-01-012023-12-3108018899ns10:Director22023-01-012023-12-3108018899ns10:Director32023-01-012023-12-3108018899ns10:RegisteredOffice2023-01-012023-12-3108018899ns5:CurrentFinancialInstruments2023-12-3108018899ns5:CurrentFinancialInstruments2022-12-3108018899ns5:ShareCapital2023-12-3108018899ns5:ShareCapital2022-12-3108018899ns5:RetainedEarningsAccumulatedLosses2023-12-3108018899ns5:RetainedEarningsAccumulatedLosses2022-12-3108018899ns5:PlantMachinery2023-01-012023-12-3108018899ns5:FurnitureFittings2023-01-012023-12-3108018899ns5:ComputerEquipment2023-01-012023-12-3108018899ns5:WithinOneYear2023-12-3108018899ns5:WithinOneYear2022-12-3108018899ns5:BetweenOneFiveYears2023-12-3108018899ns5:BetweenOneFiveYears2022-12-3108018899ns5:AllPeriods2023-12-3108018899ns5:AllPeriods2022-12-3108018899ns10:OrdinaryShareClass12023-12-31
REGISTERED NUMBER: 08018899 (England and Wales)















Financial Statements for the Year Ended 31 December 2023

for

Implantcast UK Limited

Implantcast UK Limited (Registered number: 08018899)






Contents of the Financial Statements
for the year ended 31 December 2023




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 3


Implantcast UK Limited

Company Information
for the year ended 31 December 2023







DIRECTORS: A Dring
Implantcast GmbH
J Sass





REGISTERED OFFICE: Euro Innovation Centre
Aston Cross Business Park
Rocky Lane
Birmingham
B6 5RQ





REGISTERED NUMBER: 08018899 (England and Wales)





AUDITORS: Derek Young & Co Accountants LLP
Statutory Auditors
Chartered Accountants
Estate House
Evesham Street
Redditch
Worcestershire
B97 4HP

Implantcast UK Limited (Registered number: 08018899)

Abridged Balance Sheet
31 December 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 399,773 196,896

CURRENT ASSETS
Stocks 843,233 223,065
Debtors 798,076 1,491,842
Cash at bank 676,329 806,332
2,317,638 2,521,239
CREDITORS
Amounts falling due within one year 2,755,710 3,291,952
NET CURRENT LIABILITIES (438,072 ) (770,713 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(38,299

)

(573,817

)

CAPITAL AND RESERVES
Called up share capital 6 100 100
Retained earnings (38,399 ) (573,917 )
SHAREHOLDERS' FUNDS (38,299 ) (573,817 )

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 31 December 2023 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 26 March 2024 and were signed on its behalf by:





A Dring - Director


Implantcast UK Limited (Registered number: 08018899)

Notes to the Financial Statements
for the year ended 31 December 2023

1. STATUTORY INFORMATION

Implantcast UK Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents amounts derived from the provision of goods and services falling within the company's ordinary activities, after deduction of trade discounts, value added tax and any other tax based on the amounts so derived.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have been passed to the buyer (usually on despatch of goods, or date of use of goods on consignment), the amount of revenue can me measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance and 10% on cost
Fixtures and fittings - 20% on cost
Computer equipment - 33.33% on cost

Tangible fixed assets are stated at cost less depreciation.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Implantcast UK Limited (Registered number: 08018899)

Notes to the Financial Statements - continued
for the year ended 31 December 2023

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Going concern disclosure
At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future with the continued financial support of its parent undertaking Implantcast GmbH. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 17 (2022 - 17 ) .

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 January 2023 311,234
Additions 283,858
Disposals (937 )
At 31 December 2023 594,155
DEPRECIATION
At 1 January 2023 114,338
Charge for year 80,796
Eliminated on disposal (752 )
At 31 December 2023 194,382
NET BOOK VALUE
At 31 December 2023 399,773
At 31 December 2022 196,896

5. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2023 2022
£    £   
Within one year 8,704 -
Between one and five years 244,245 348,969
252,949 348,969

6. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
100 Ordinary £1 100 100

Implantcast UK Limited (Registered number: 08018899)

Notes to the Financial Statements - continued
for the year ended 31 December 2023

7. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Mr Stephen Young FCA (Senior Statutory Auditor)
for and on behalf of Derek Young & Co Accountants LLP

8. ULTIMATE CONTROLLING PARTY

The company is under the control of Implantcast GmbH, a company incorporated in Germany, which owns 100% of the share capital, The consolidated accounts of Implantcast GmbH can be obtained from Luneburger Schanze 26. D-21614 Buxtehude, Hamburg, Germany.

N Mohr is the ultimate controlling party by virtue of his ownership of 65% of Implantcast GmbH's share capital.